Update information

Update information

February 2015: We have removed reference to throat swabs from recommendation 1.3.14, to bring the recommendation into line with Public Health England's Guidance on the public health management of  meningococcal disease in the UK.

September 2010: The hydrocortisone dosage in recommendation 1.4.45 relating to steroid replacement therapy using low-dose corticosteroids in children and young people with shock that is unresponsive to vasoactive agents has been amended. The original recommendation stated:

In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 0.25 mg/m 2 four times daily) should be used only when directed by a paediatric intensivist.

The corrected recommendation reads:

In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 25 mg/m 2 four times daily) should be used only when directed by a paediatric intensivist.

This web version has been amended to reflect this correction.

Minor changes since publication

October 2018: After a surveillance review, links to other NICE guidelines and external websites have been updated or replaced if needed.

ISBN: 978-1-4731-3040-1

  • National Institute for Health and Care Excellence (NICE)